×

LLY – eli lilly & co (US:NYSE)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day —— LLY SPY QQQ SPX
Main News & Impact Reports
Date
Time
Symbol
Company Name
Action
%Chg
Access the LLY Earnings page here
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
Date
Time
Action
From
To
Firm
Impact
%Chg
Check out additional upgrades and downgrades for LLY by here
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny

Odd Lot

Avg. bid-ask spread

Avg. bid / ask size


Shares at ask / bid


Off exchange

TOP News Gainers
11/6 Eli Lilly And Co (NYSE: LLY) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 3.6%
12/27 Eli Lilly And Co (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Argus. 3.4%
1/4 Mother says son died because he couldn’t afford insulin [CBS News] 3.2%
11/5 Initial results from EMPRISE real-world evidence study show Jardiance® was associated with reduced risk for hospitalization for heart failure compared with DPP-4 inhibitors in people with type 2 diabetes with and without cardiovascular disease 3.2%
1/15 Array Bio up 11% premarket on positive late-stage data on triplet therapy for certain type of colorectal cancer [Seeking Alpha] 2.7%
8/8 Lilly, Evidation Health and Apple Study Shows Personal Digital Devices May Help in the Identification of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia 2.6%
8/26 Lilly Receives U.S. FDA Approval for Taltz® (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis) 2.6%
1/31 FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer 2.5%
12/18 Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies 2.5%
9/10 Eli Lilly And Co (NYSE: LLY) had its "neutral" rating re-affirmed by analysts at Bank of America Corp. They now have a $120.00 price target on the stock, up previously from $118.00. 2.1%

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below:

Live Event: Join our next subscriber-only event: CPR Strategy

Tuesday August 14th at 12:00 AM ET

Get your questions answered during the Q & A session.

For any support questions, contact our team: support@newsquantified.com

REGISTER TO LIVE EVENT

Don’t Miss Out On The Next BIG Stock Move

"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below:

Live Event: Join our next subscriber-only event: CPR Strategy

Register for our next upcoming LIVE training session, which will be hosted on Tuesday August 14th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: "Bootcamp (Trading Plan)"

Register for our next upcoming LIVE training session, which will be hosted on Wednesday August 15th at 12:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: CPR Strategy

Register for our next upcoming LIVE training session, which will be hosted on Tuesday August 14th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Live Event: Join our next subscriber-only event: Bootcamp (Trading Plan)

Register for our next upcoming LIVE training session, which will be hosted on Wednesday August 15th at 12:00 AM ET
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com